000			02253 a2200685 4500
005			20250518075249.0
264		0	_c20201005
008			202010s 0 0 eng d
022			_a1872-7980
024	7		_a10.1016/j.canlet.2019.12.025 _2doi
040			_aNLM _beng _cNLM
100	1		_aRay, Jessica
245	0	0	_amiR-191 promotes radiation resistance of prostate cancer through interaction with RXRA. _h[electronic resource]
260			_bCancer letters _c03 2020
300			_a107-117 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAlitretinoin _xadministration & dosage
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aBiomarkers, Tumor _xmetabolism
650	0	4	_aCell Line, Tumor
650	0	4	_aChemoradiotherapy, Adjuvant _xmethods
650	0	4	_aDisease-Free Survival
650	0	4	_aDown-Regulation
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aGene Knockdown Techniques
650	0	4	_aHumans
650	0	4	_aKallikreins _xblood
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMicroRNAs _xagonists
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Grading
650	0	4	_aNeoplasm Recurrence, Local _xblood
650	0	4	_aPrimary Cell Culture
650	0	4	_aPrognosis
650	0	4	_aProstate _xpathology
650	0	4	_aProstate-Specific Antigen _xblood
650	0	4	_aProstatectomy
650	0	4	_aProstatic Neoplasms _xblood
650	0	4	_aRadiation Tolerance _xdrug effects
650	0	4	_aRetinoid X Receptor alpha _xagonists
650	0	4	_aSurvival Rate
650	0	4	_aTime Factors
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aHaughey, Charles
700	1		_aHoey, Christianne
700	1		_aJeon, Jouhyun
700	1		_aMurphy, Ross
700	1		_aDura-Perez, Lara
700	1		_aMcCabe, Nuala
700	1		_aDownes, Michelle
700	1		_aJain, Suneil
700	1		_aBoutros, Paul C
700	1		_aMills, Ian G
700	1		_aLiu, Stanley K
773	0		_tCancer letters _gvol. 473 _gp. 107-117
856	4	0	_uhttps://doi.org/10.1016/j.canlet.2019.12.025 _zAvailable from publisher's website
999			_c30456815 _d30456815